ABSTRACT
Ombrotrophic peatland-fed solely from atmospheric deposition of nutrients and precipitation-provide unique archives of atmospheric pollution and have been used to illustrate trends and changes in atmospheric trace element composition from the recent decadal to the Holocene period. With the acknowledgment of atmosphere plastic pollution, analysis of ombrotrophic peat presents an opportunity to characterize the historical atmospheric microplastic pollution prevalence. Ombrotrophic peatland is often located in comparatively pristine mountainous and boreal areas, acting as sentinels of environmental change. In this paired site study, a Sphagnum ombrotrophic peat record is used for the first time to identify the trend of atmospheric microplastic pollution. This high altitude, remote location ombrotrophic peat archive pilot study identifies microplastic presence in the atmospheric pollution record, increasing from <5(±1) particles/m2/day in the 1960s to 178(±72) particles/m2/day in 2015-2020 in a trend similar to the European plastic production and waste management. Compared to this catchment's lake sediment archive, the ombrotrophic peat core appears to be effective in collecting and representing atmospheric microplastic deposition in this remote catchment, collecting microplastic particles that are predominantly ≤20 µm. This study suggests that peat records may be a useful tool in assessing the past quantities and trends of atmospheric microplastic.
ABSTRACT
Pharmaceutical products (PPs) are consumed worldwide and are continuously released into hydrological environments, but are not efficiently removed by sewage treatment plants. Their occurrence within the dissolved phase has been extensively studied, but only a few articles concern solid matrices. The mechanisms and extent of sorption depend on the properties of both the molecules (degradability, charge, hydrophobicity) and the matrices (clay content, organic matter content), making the spatio-temporal distribution of PPs in natural environments complex and poorly elucidated. To improve our understanding of PP distribution at a catchment scale, this study investigated different groups of molecules with varying solubility and charges, in water, suspended particulate matter, bed-load and pond sediments. The Egoutier stream, which collects the sewage effluents from two health institutions sewage effluents, is a good candidate for this investigation. Results indicate that PP occurrences in the different particulate compartments were mainly regulated by their wastewater occurrences and charges. Particulate phases all along the Egoutier stream were characterized by a limited clay content (i.e. less than 1%) and significant organic carbon content (i.e. between 0.3% and 18.0%) favouring non-specific adsorption. Therefore, neutral PPs, exhibiting higher discharge rates, persistence and hydrophobicities in comparison with cationic and anionic molecules, were the most abundant PPs in the particulate phases of this catchment. In bed-load sediments, global PP spatial distributions reflected discharge sites and sedimentary accumulation zones, mostly that of organic matter. Spatial distributions of the more hydrophobic and persistent PP in the particulate phases thus followed the stream sedimentary dynamic.
Subject(s)
Pharmaceutical Preparations , Water Pollutants, Chemical , Environmental Monitoring , Geologic Sediments , Rivers , Water Pollutants, Chemical/analysisABSTRACT
In 2007, four patients where implanted with the Restore neurostimulation system for intractable chronic leg pain at the Poitiers Hospital. The potential for improving the patients' quality of life and medical-economic concerns motivated this choice for these highly selected patients. In this paper, we propose brief clinical case reports and discuss the reasons for choosing this new rechargeable system, even though it was initially more expensive than the standard neurostimulation system (Itrel 3). All patients receiving implants declared that they were very satisfied with the quality of stimulation provided by Restore and noted a significant improvement in their quality of life. If this solution becomes advantageous from an economic point of view, clinical data should lend support to the utility of this technological innovation for patients who have hitherto been in treatment failure.
